253 related articles for article (PubMed ID: 21569303)
1. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.
Vilardell M; Rasche A; Thormann A; Maschke-Dutz E; Pérez-Jurado LA; Lehrach H; Herwig R
BMC Genomics; 2011 May; 12():229. PubMed ID: 21569303
[TBL] [Abstract][Full Text] [Related]
2. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
4. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.
Li C; Jin L; Bai Y; Chen Q; Fu L; Yang M; Xiao H; Zhao G; Wang S
PLoS One; 2012; 7(11):e49130. PubMed ID: 23155455
[TBL] [Abstract][Full Text] [Related]
6. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21.
Miyamoto K; Suzuki N; Sakai K; Asakawa S; Okazaki T; Kudoh J; Ikeno M; Shimizu N
Transgenic Res; 2014 Apr; 23(2):317-29. PubMed ID: 24293126
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome.
De Toma I; Sierra C; Dierssen M
PLoS Comput Biol; 2021 Sep; 17(9):e1009317. PubMed ID: 34570756
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray.
Chung IH; Lee SH; Lee KW; Park SH; Cha KY; Kim NS; Yoo HS; Kim YS; Lee S
J Korean Med Sci; 2005 Feb; 20(1):82-7. PubMed ID: 15716609
[TBL] [Abstract][Full Text] [Related]
11. C21orf5, a new member of Dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome.
Rachidi M; Lopes C; Costantine M; Delabar JM
DNA Res; 2005; 12(3):203-10. PubMed ID: 16303751
[TBL] [Abstract][Full Text] [Related]
12. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
13. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
Engidawork E; Baiic N; Fountoulakis M; Dierssen M; Greber-Platzer S; Lubec G
J Neural Transm Suppl; 2001; (61):335-46. PubMed ID: 11771756
[TBL] [Abstract][Full Text] [Related]
15. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.
Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M
Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590
[TBL] [Abstract][Full Text] [Related]
16. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
17. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
18. Ohnologs in the human genome are dosage balanced and frequently associated with disease.
Makino T; McLysaght A
Proc Natl Acad Sci U S A; 2010 May; 107(20):9270-4. PubMed ID: 20439718
[TBL] [Abstract][Full Text] [Related]
19. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV).
Cheon MS; Shim KS; Kim SH; Hara A; Lubec G
Amino Acids; 2003 Jul; 25(1):41-7. PubMed ID: 12836057
[TBL] [Abstract][Full Text] [Related]
20. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
